Hsbc Holdings PLC Seagen Inc. Transaction History

Hsbc Holdings PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $22 Million - $24.8 Million	-114,732 Reduced 36.94%	195,833 $41.5 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $192,143 - $211,200	-1,024 Reduced 0.33%	310,565 $59.8 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $2.58 Million - $4.1 Million	-20,195 Reduced 6.09%	311,589 $63.1 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $23.8 Million - $28.2 Million	202,685 Added 157.0%	331,784 $42.6 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $9.82 Million - $13.1 Million	72,616 Added 128.56%	129,099 $17.7 Million
Q2 2022 Aug 11, 2022	SELL	$108.81 - $179.33 $665,590 - $1.1 Million	-6,117 Reduced 9.77%	56,483 $10 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $7.09 Million - $9.36 Million	-59,285 Reduced 48.64%	62,600 $9.01 Million
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $10.5 Million - $14 Million	73,609 Added 152.48%	121,885 $18.8 Million
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $711,537 - $848,250	4,995 Added 11.54%	48,276 $8.15 Million
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $1.38 Million - $1.65 Million	10,228 Added 30.94%	43,281 $6.83 Million
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $317,098 - $439,984	2,306 Added 7.5%	33,053 $4.59 Million
Q4 2020 Feb 25, 2021	SELL	$164.63 - $211.93 $49,389 - $63,579	-300 Reduced 0.97%	30,747 $5.39 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $5.11 Million - $6.58 Million	31,047 New	31,047 $5.44 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.